Taking an in-vitro diagnostic (IVD) product from laboratory concept to commercial launch is a complex and high-risk process. The core operational challenge is transforming a promising prototype into a fully regulated, mass-manufactured product without encountering hurdles such as yield issues, material changes, single-supplier dependencies, or documentation breakdowns. Regulatory complexity and supply chain vulnerability remain the two critical IVD commercialization risk factors.
To address these challenges, Syrma Johari MedTech has developed a practical, stage-wise knowledge guide that takes IVD developers from concept to full-scale, regulatory-compliant production.
This knowledge guide is a tactical operating manual for MedTech teams navigating the real-world challenges of IVD scale-up. It outlines:
By using this blueprint as a reference, MedTech companies can ensure that their IVD innovations are ready for high-volume manufacturing and global regulatory scrutiny.
Syrma Johari MedTech provides an end-to-end ecosystem that combines design, prototyping, manufacturing, and QARA expertise. We empower OEMs to bring complex diagnostic technologies to market faster and with complete regulatory confidence.
Partner with Syrma Johari MedTech to turn your IVD concept into a compliant, scalable, and market-ready solution.
